drugset / Trial / NCT00303290
PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CML
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to see if a new interferon which is given only once a week with ARA-C works as well as standard interferon and low dose ARA-C. The safety of this treatment will also be studied.
Timeline
- Start
- 2000-01
- Primary completion
- 2014-11
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cytarabine | Small molecule | 10 mg | Subcutaneous |
| Subject | Peginterferon alfa-2b | Protein / enzyme biologic | 4.5 ug/kg | — |